BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21962898)

  • 1. Paratesticular leiomyoma with a der(14)t(12;14)(q15;q24).
    Gorunova L; Bjerkehagen B; Heim S
    Cancer Genet; 2011 Aug; 204(8):465-8. PubMed ID: 21962898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous leiomyomatosis is characterized by a der(14)t(12;14)(q15;q24).
    Dal Cin P; Quade BJ; Neskey DM; Kleinman MS; Weremowicz S; Morton CC
    Genes Chromosomes Cancer; 2003 Feb; 36(2):205-6. PubMed ID: 12508249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of novel human transcripts embedded within HMGA2 in t(12;14)(q15;q24.1) uterine leiomyoma.
    Ingraham SE; Lynch RA; Surti U; Rutter JL; Buckler AJ; Khan SA; Menon AG; Lepont P
    Mutat Res; 2006 Dec; 602(1-2):43-53. PubMed ID: 17045619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15.
    Quade BJ; Weremowicz S; Neskey DM; Vanni R; Ladd C; Dal Cin P; Morton CC
    Cancer Res; 2003 Mar; 63(6):1351-8. PubMed ID: 12649198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of HMGIC in a uterine lipoleiomyoma with a complex rearrangement including chromosomes 7, 12, and 14.
    Pedeutour F; Quade BJ; Sornberger K; Tallini G; Ligon AH; Weremowicz S; Morton CC
    Genes Chromosomes Cancer; 2000 Feb; 27(2):209-15. PubMed ID: 10612811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.
    Klemke M; Meyer A; Nezhad MH; Bartnitzke S; Drieschner N; Frantzen C; Schmidt EH; Belge G; Bullerdiek J
    Genes Chromosomes Cancer; 2009 Feb; 48(2):171-8. PubMed ID: 18980243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of HMGA2 to COG5 in uterine leiomyoma.
    Velagaleti GV; Tonk VS; Hakim NM; Wang X; Zhang H; Erickson-Johnson MR; Medeiros F; Oliveira AM
    Cancer Genet Cytogenet; 2010 Oct; 202(1):11-6. PubMed ID: 20804914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and functional map of the chromosome 14 t(12;14) breakpoint cluster region in uterine leiomyoma.
    Lynch RA; Piper M; Bankier A; Bhugra B; Surti U; Liu J; Buckler A; Dear PH; Menon AG
    Genomics; 1998 Aug; 52(1):17-26. PubMed ID: 9740667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6p21 rearrangements in uterine leiomyomas targeting HMGA1.
    Nezhad MH; Drieschner N; Helms S; Meyer A; Tadayyon M; Klemke M; Belge G; Bartnitzke S; Burchardt K; Frantzen C; Schmidt EH; Bullerdiek J
    Cancer Genet Cytogenet; 2010 Dec; 203(2):247-52. PubMed ID: 21156240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of a breakpoint cluster region on chromosome 14 in uterine leiomyoma.
    Bhugra B; Smolarek TA; Lynch RA; Meloni AM; Sandberg AA; Deaven L; Menon AG
    Cancer Lett; 1998 Apr; 126(2):119-26. PubMed ID: 9585056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent breakpoints in region 14q22-q24 in uterine leiomyoma.
    Turc-Carel C; Dal Cin P; Boghosian L; Terk-Zakarian J; Sandberg AA
    Cancer Genet Cytogenet; 1988 May; 32(1):25-31. PubMed ID: 3355998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation (Y;12) in lipoma.
    Liang CW; Mariño-Enríquez A; Johannessen C; Hornick JL; Dal Cin P
    Cancer Genet; 2011 Jan; 204(1):53-6. PubMed ID: 21356192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function.
    Hunter DS; Klotzbücher M; Kugoh H; Cai SL; Mullen JP; Manfioletti G; Fuhrman U; Walker CL
    Cancer Res; 2002 Jul; 62(13):3766-72. PubMed ID: 12097287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericentric inversion (12)(p12q13-14) as the sole chromosomal abnormality in a leiomyoma of the vulva.
    Guardiola MT; Dobin SM; Dal Cin P; Donner LR
    Cancer Genet Cytogenet; 2010 May; 199(1):21-3. PubMed ID: 20417864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A preliminary cytogenetic study of uterine leiomyoma].
    Xiu ZF
    Zhonghua Fu Chan Ke Za Zhi; 1993 Feb; 28(2):91-3, 123. PubMed ID: 8344090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.
    Markowski DN; von Ahsen I; Nezhad MH; Wosniok W; Helmke BM; Bullerdiek J
    Genes Chromosomes Cancer; 2010 Aug; 49(8):661-8. PubMed ID: 20544840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).
    Takahashi K; Kawamura N; Ishiko O; Ogita S
    Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata.
    Fejzo MS; Yoon SJ; Montgomery KT; Rein MS; Weremowicz S; Krauter KS; Dorman TE; Fletcher JA; Mao JI; Moir DT
    Genomics; 1995 Mar; 26(2):265-71. PubMed ID: 7601452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine leiomyoma cytogenetics.
    Nibert M; Heim S
    Genes Chromosomes Cancer; 1990 May; 2(1):3-13. PubMed ID: 2278965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic heterogeneity in leiomyomas of deep soft tissue.
    Panagopoulos I; Gorunova L; Brunetti M; Agostini A; Andersen HK; Lobmaier I; Bjerkehagen B; Heim S
    Oncotarget; 2017 Jul; 8(30):48769-48781. PubMed ID: 28591699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.